| Accession |
GSE80131
|
| Status |
2016/7/11 |
| Title |
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing |
| Summary |
The host innate immune response is the first line of defense against pathogens and is orchestrated by the concerted expression of genes induced by microbial stimuli. Deregulated expression of these genes is linked to the initiation and progression of numerous diseases associated with exacerbated inflammation. Here, we identify Topoisomerase 1 (Top1) as a critical positive regulator of RNA polymerase II (RNAPII) transcriptional activity at pathogen-induced genes. Notably, depletion or chemical inhibition of Top1 suppresses the host response against replicating Influenza and Ebola viruses as well as bacterial products. As a result, therapeutic pharmacological inhibition of Top1 protects mice from death in experimental models of chemical- and pathogen-induced lethal inflammation. Our results indicate that Top1 inhibition could be used as therapy against life threatening infections characterized by an acutely exacerbated immune response. |
| Samples |
| GSM ID |
Sample info |
Characteristics |
Description |
|
GSM2113344
|
Mock Campothecin |
cell type:THP-1; treatment:Campothecin |
RNA sequencing |
|
GSM2113345
|
Mock DMSO |
cell type:THP-1; treatment:DMSO |
RNA sequencing |
|
GSM2113346
|
Mutated Ebola Campothecin |
cell type:THP-1; treatment:Campothecin |
RNA sequencing |
|
GSM2113347
|
Mutated Ebola DMSO |
cell type:THP-1; treatment:DMSO |
RNA sequencing |
|
GSM2113348
|
Wild-type Ebola Campothecin |
cell type:THP-1; treatment:Campothecin |
RNA sequencing |
|
GSM2113349
|
Wild-type Ebola DMSO |
cell type:THP-1; treatment:DMSO |
RNA sequencing |
|
| Platform |
GPL16791 : Illumina HiSeq 2500 (Homo sapiens) |
| Literature |
27127234 |
| Download |
Download xCell Data Download Expression Analysis Data
|
|
xCell Plot
|
|
* p<0.05 ** p<0.01
|